封面
市場調查報告書
商品編碼
1332133

宮頸發育異常診斷的全球市場

Cervical Dysplasia Diagnostics

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年,全球宮頸不典型增生診斷市場將達到 8.046 億美元

隨著Covid-19後商業格局的變化,宮頸不典型增生診斷的全球市場預計2022年為5.094億美元,到2030年將修正為8.046億美元,預計2022年年複合成長率為5.9% 2020年至2030年。診斷測試是本報告分析的細分市場之一,預計複合年成長率為 6%,到分析期結束時將達到 7.122 億美元。鑑於大流行後的持續復甦,未來八年診斷設備細分市場的年複合成長率預計為 5.1%。

美國市場預計將成長1.53億美元,中國年複合成長率為5.4%

到 2022 年,美國宮頸不典型增生診斷市場預計將達到 1.53 億美元。中國作為世界第二大經濟體,預計到2030年市場規模將達到1.393億美元,2022年至2030年的分析期間年複合成長率為5.4%。其他值得注意的地域市場包括日本和加拿大,預計 2022 年至 2030 年將分別成長 5.5% 和 4.7%。在歐洲,德國的年複合成長率預計約為 4.8%。

受訪企業示例

  • Abbott Molecular, Inc.
  • Becton, Dickinson & Company
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • QIAGEN GmbH
  • Quest Diagnostics, Inc.

目錄

第1章 調查方法

第2章 執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 競爭

簡介目錄
Product Code: MCP16261

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Cervical Dysplasia Diagnostics Market to Reach $804.6 Million by 2030

In the changed post COVID-19 business landscape, the global market for Cervical Dysplasia Diagnostics estimated at US$509.4 Million in the year 2022, is projected to reach a revised size of US$804.6 Million by 2030, growing at aCAGR of 5.9% over the period 2022-2030. Diagnostic Tests, one of the segments analyzed in the report, is projected to record 6% CAGR and reach US$712.2 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Diagnostic Devices segment is readjusted to a revised 5.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $153 Million, While China is Forecast to Grow at 5.4% CAGR

The Cervical Dysplasia Diagnostics market in the U.S. is estimated at US$153 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$139.3 Million by the year 2030 trailing a CAGR of 5.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.5% and 4.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Select Competitors (Total 46 Featured) -

  • Abbott Molecular, Inc.
  • Becton, Dickinson & Company
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • QIAGEN GmbH
  • Quest Diagnostics, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Cervical Dysplasia Diagnostics - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Cervical Dysplasia Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Cervical Dysplasia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Private Gynecologists' Offices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Private Gynecologists' Offices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Private Gynecologists' Offices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Research & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Research & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Research & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Cervical Dysplasia Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2014, 2023 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2014, 2023 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2014, 2023 & 2030
  • JAPAN
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2014, 2023 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2014, 2023 & 2030
  • CHINA
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: China 16-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2014, 2023 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: China 16-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2014, 2023 & 2030
  • EUROPE
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cervical Dysplasia Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Cervical Dysplasia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2014, 2023 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2014, 2023 & 2030
  • FRANCE
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: France 16-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2014, 2023 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: France 16-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2014, 2023 & 2030
  • GERMANY
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2014, 2023 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2014, 2023 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2014, 2023 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2014, 2023 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2014, 2023 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2014, 2023 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2014, 2023 & 2030

IV. COMPETITION